Provider
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Program effective Date: Mar 21, 2017
Search Results
Displaying 2591 - 2600 of 4269 results
Provider
P48-17 EquiClaim to Perform Focused and Limited Hospital Bill Validation Services
Program effective Date: Sep 19, 2017
Provider
P21-17 New Drug-Related Prior Authorization with Quantity Limit for Entresto
Program effective Date: May 08, 2017
Provider
P45-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Concurrent Opioids with Buprenorphine
Program effective Date: Aug 14, 2017
Provider
P13-17 Added Reimbursement Policy for General Coding: Total Parenteral Nutrition Billing
Program effective Date: Apr 07, 2017
Provider
P42-17 Addition of Drugs to Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Aug 03, 2017
Provider
P77-17 Medicare Advantage Process for NOMNC Letter
Program effective Date: Dec 12, 2017
Provider
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Program effective Date: Aug 14, 2017
Provider
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Program effective Date: Apr 28, 2017
Provider
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Program effective Date: Aug 01, 2018